Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| May 8, 2026 | CMS / Medicare | MDS FISH | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: MolDX: Breast Cancer Assay: Prosigna | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Respiratory Care (Respiratory Therapy) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis | Metadata changed |
| May 8, 2026 | CMS / Medicare | MolDX: Inivata, InVisionFirst, Liquid Biopsy for Patients with Lung Cancer | Metadata changed |
| May 8, 2026 | CMS / Medicare | Percutaneous Coronary Intervention | Metadata changed |
| May 8, 2026 | CMS / Medicare | Special Electroencephalography | Metadata changed |
| May 8, 2026 | CMS / Medicare | Supervised Exercise Therapy for the Treatment of Peripheral Arterial Disease with Symptomatic Lower Extremity Intermittent Claudication | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Molecular Pathology Procedures | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: MolDX: Plasma-Based Genomic Profiling in Solid Tumors (L38168) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Radiation Therapies | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Visual Electrophysiology Testing (L37015) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Phrenic Nerve Stimulator | Metadata changed |
| May 8, 2026 | CMS / Medicare | Immune Globulin Intravenous (IVIg) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Drugs and Biologicals, Coverage of, for Label and Off-Label Uses | Metadata changed |
| May 8, 2026 | CMS / Medicare | Percutaneous Vertebral Augmentation (PVA) for Osteoporotic Vertebral Compression Fracture (VCF) | Metadata changed |
| May 8, 2026 | CMS / Medicare | MolDX: Minimal Residual Disease Testing for Cancer | Metadata changed |
| May 8, 2026 | CMS / Medicare | Home Use of Oxygen in Approved Clinical Trials | Metadata changed |
| May 8, 2026 | CMS / Medicare | MolDX: HLA-DQB1*06:02 Testing for Narcolepsy | Metadata changed |
| May 8, 2026 | CMS / Medicare | Rituximab | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Bladder/Urothelial Tumor Markers | Metadata changed |
| May 8, 2026 | CMS / Medicare | Fluid Jet System in the Treatment of Benign Prostatic Hyperplasia (BPH) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Diagnostic and Therapeutic Colonoscopy | Metadata changed |
| May 8, 2026 | CMS / Medicare | Transesophageal Echocardiography (TEE) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Billing and Coding: Patients Supplied Donated or Free-of-Charge Drug | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: MolDX: Molecular Testing for Solid Organ Allograft Rejection | Metadata changed |
| May 8, 2026 | CMS / Medicare | Surgical Treatment of Nails | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: MolDX: Inivata, InVisionFirst, Liquid Biopsy for Patients with Lung Cancer | Metadata changed |
| May 8, 2026 | CMS / Medicare | Thermal Intradiscal Procedures (TIPs) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Cosmetic and Reconstructive Surgery | Metadata changed |
| May 8, 2026 | CMS / Medicare | Granulocyte Transfusions | Metadata changed |
| May 8, 2026 | CMS / Medicare | Sleep Testing for Obstructive Sleep Apnea (OSA) | Metadata changed |
| May 8, 2026 | CMS / Medicare | MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer | Metadata changed |
| May 8, 2026 | CMS / Medicare | MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease | Metadata changed |
| May 8, 2026 | CMS / Medicare | Extracorporeal Photopheresis | Metadata changed |
| May 8, 2026 | CMS / Medicare | Non-Coronary Vascular Stents | Metadata changed |
| May 8, 2026 | CMS / Medicare | Psychiatric Partial Hospitalization Programs | Metadata changed |
| May 8, 2026 | CMS / Medicare | Sacral Nerve Stimulation for the Treatment of Urinary and Fecal Incontinence | Metadata changed |
| May 8, 2026 | CMS / Medicare | Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease (DL38839) | Metadata changed |
| May 8, 2026 | CMS / Medicare | EEG Ambulatory Monitoring | Metadata changed |
| May 8, 2026 | CMS / Medicare | Percutaneous Transluminal Angioplasty (PTA) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Outpatient Physical and Occupational Therapy Services | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Implantable Continuous Glucose Monitors (I-CGM) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Cerumen (Earwax) Removal | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: MolDX: EndoPredict® Breast Cancer Gene Expression Test | Metadata changed |
| May 8, 2026 | CMS / Medicare | Magnetic Resonance Angiography (MRA) | Metadata changed |